 Ramon Lorca
Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vasodilation | 6 | 2022 | 521 | 2.140 |
Why?
| | Placenta | 11 | 2025 | 786 | 1.960 |
Why?
| | Altitude | 7 | 2024 | 463 | 1.500 |
Why?
| | Uterine Artery | 7 | 2024 | 74 | 1.280 |
Why?
| | Altitude Sickness | 3 | 2022 | 141 | 1.270 |
Why?
| | Arteries | 3 | 2022 | 261 | 1.190 |
Why?
| | Pre-Eclampsia | 3 | 2023 | 206 | 1.180 |
Why?
| | AMP-Activated Protein Kinases | 6 | 2025 | 192 | 1.090 |
Why?
| | Fetal Growth Retardation | 10 | 2025 | 593 | 1.090 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 3 | 2017 | 10 | 1.030 |
Why?
| | Muscle, Smooth, Vascular | 3 | 2019 | 449 | 0.940 |
Why?
| | Pregnancy | 24 | 2025 | 7202 | 0.940 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channel beta Subunits | 2 | 2017 | 8 | 0.940 |
Why?
| | Potassium Channels | 2 | 2022 | 147 | 0.870 |
Why?
| | Myometrium | 3 | 2020 | 38 | 0.830 |
Why?
| | Placental Circulation | 7 | 2025 | 71 | 0.800 |
Why?
| | Large-Conductance Calcium-Activated Potassium Channels | 3 | 2018 | 11 | 0.770 |
Why?
| | Uterus | 3 | 2022 | 227 | 0.680 |
Why?
| | Zinc | 4 | 2011 | 306 | 0.650 |
Why?
| | Nitric Oxide Synthase | 1 | 2019 | 234 | 0.560 |
Why?
| | Protein Kinases | 1 | 2020 | 312 | 0.550 |
Why?
| | Copper | 4 | 2007 | 119 | 0.510 |
Why?
| | Hypoxia | 8 | 2024 | 1199 | 0.500 |
Why?
| | Receptors, Purinergic P2 | 5 | 2024 | 23 | 0.450 |
Why?
| | Sodium | 2 | 2025 | 198 | 0.400 |
Why?
| | CA1 Region, Hippocampal | 2 | 2011 | 49 | 0.400 |
Why?
| | Fetal Development | 3 | 2025 | 298 | 0.380 |
Why?
| | Receptors, Cell Surface | 2 | 2025 | 372 | 0.370 |
Why?
| | Endothelium, Vascular | 1 | 2019 | 956 | 0.370 |
Why?
| | PPAR gamma | 3 | 2020 | 178 | 0.360 |
Why?
| | Receptors, Purinergic P2X | 2 | 2011 | 7 | 0.350 |
Why?
| | Gene Expression Regulation | 2 | 2021 | 2597 | 0.350 |
Why?
| | Long-Term Potentiation | 2 | 2011 | 199 | 0.350 |
Why?
| | Fetal Hypoxia | 2 | 2024 | 56 | 0.340 |
Why?
| | Signal Transduction | 4 | 2025 | 5216 | 0.330 |
Why?
| | Adenosine Triphosphate | 5 | 2022 | 500 | 0.320 |
Why?
| | Trophoblasts | 2 | 2025 | 218 | 0.310 |
Why?
| | Hypertension, Renovascular | 2 | 2025 | 15 | 0.280 |
Why?
| | Female | 26 | 2025 | 78845 | 0.280 |
Why?
| | Animals | 29 | 2025 | 38030 | 0.280 |
Why?
| | Calcium | 1 | 2014 | 1190 | 0.260 |
Why?
| | Blood Pressure | 3 | 2025 | 1779 | 0.260 |
Why?
| | Nitric Oxide | 3 | 2020 | 892 | 0.250 |
Why?
| | Histidine | 2 | 2005 | 66 | 0.240 |
Why?
| | Prions | 2 | 2003 | 56 | 0.240 |
Why?
| | Peptide Fragments | 3 | 2025 | 693 | 0.230 |
Why?
| | Vacuolar Proton-Translocating ATPases | 1 | 2025 | 15 | 0.220 |
Why?
| | Epithelial Sodium Channels | 1 | 2025 | 21 | 0.220 |
Why?
| | Kidney Tubules, Collecting | 1 | 2024 | 27 | 0.210 |
Why?
| | Middle Cerebral Artery | 1 | 2024 | 56 | 0.210 |
Why?
| | HEK293 Cells | 3 | 2017 | 741 | 0.210 |
Why?
| | Purinergic P2 Receptor Antagonists | 2 | 2005 | 11 | 0.210 |
Why?
| | Placental Insufficiency | 2 | 2023 | 126 | 0.210 |
Why?
| | Ion Channels | 2 | 2023 | 129 | 0.200 |
Why?
| | Repetitive Sequences, Amino Acid | 1 | 2003 | 19 | 0.200 |
Why?
| | Mice | 15 | 2025 | 18329 | 0.190 |
Why?
| | Nitric Oxide Synthase Type I | 2 | 2020 | 30 | 0.190 |
Why?
| | Humans | 23 | 2025 | 145475 | 0.180 |
Why?
| | Amino Acids | 3 | 2023 | 519 | 0.180 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2025 | 456 | 0.180 |
Why?
| | Ileum | 2 | 2020 | 112 | 0.180 |
Why?
| | RGS Proteins | 2 | 2012 | 17 | 0.170 |
Why?
| | Fetus | 3 | 2025 | 804 | 0.170 |
Why?
| | Up-Regulation | 1 | 2024 | 847 | 0.170 |
Why?
| | Cystathionine gamma-Lyase | 1 | 2020 | 13 | 0.170 |
Why?
| | Birth Weight | 2 | 2024 | 514 | 0.160 |
Why?
| | Structure-Activity Relationship | 2 | 2017 | 563 | 0.160 |
Why?
| | Patch-Clamp Techniques | 5 | 2013 | 289 | 0.160 |
Why?
| | Pyrones | 1 | 2020 | 11 | 0.160 |
Why?
| | Maternal-Fetal Exchange | 1 | 2021 | 170 | 0.160 |
Why?
| | Hydrogen Sulfide | 1 | 2020 | 47 | 0.160 |
Why?
| | Kidney | 2 | 2025 | 1497 | 0.160 |
Why?
| | Biphenyl Compounds | 1 | 2020 | 67 | 0.150 |
Why?
| | Thiophenes | 1 | 2020 | 117 | 0.150 |
Why?
| | Gastrointestinal Motility | 1 | 2019 | 29 | 0.150 |
Why?
| | Receptors, Purinergic P2X4 | 3 | 2011 | 6 | 0.150 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2020 | 125 | 0.150 |
Why?
| | Myocytes, Smooth Muscle | 3 | 2016 | 270 | 0.140 |
Why?
| | Ion Channel Gating | 2 | 2017 | 94 | 0.140 |
Why?
| | Gene Expression | 1 | 2023 | 1476 | 0.140 |
Why?
| | Endothelin-1 | 1 | 2020 | 181 | 0.140 |
Why?
| | Rats | 7 | 2019 | 5584 | 0.140 |
Why?
| | Electrophysiology | 2 | 2011 | 218 | 0.140 |
Why?
| | Adaptation, Physiological | 1 | 2021 | 560 | 0.130 |
Why?
| | Protein Subunits | 1 | 2018 | 229 | 0.130 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2019 | 440 | 0.130 |
Why?
| | Adult | 7 | 2024 | 40777 | 0.120 |
Why?
| | Mice, Knockout | 3 | 2024 | 3124 | 0.120 |
Why?
| | Trace Elements | 2 | 2007 | 52 | 0.120 |
Why?
| | Xenopus laevis | 3 | 2005 | 104 | 0.120 |
Why?
| | alpha-Macroglobulins | 1 | 2016 | 25 | 0.120 |
Why?
| | Oocytes | 3 | 2005 | 185 | 0.110 |
Why?
| | Renin-Angiotensin System | 2 | 2025 | 80 | 0.100 |
Why?
| | Uterine Contraction | 1 | 2014 | 17 | 0.100 |
Why?
| | Calcium Signaling | 1 | 2016 | 245 | 0.100 |
Why?
| | Kinetics | 1 | 2017 | 1567 | 0.100 |
Why?
| | Transcription Factor RelA | 1 | 2014 | 86 | 0.100 |
Why?
| | Microscopy, Confocal | 1 | 2014 | 319 | 0.100 |
Why?
| | Mice, Inbred C57BL | 6 | 2025 | 5983 | 0.100 |
Why?
| | Neurons | 3 | 2019 | 1649 | 0.100 |
Why?
| | Image Enhancement | 1 | 2014 | 200 | 0.100 |
Why?
| | TRPM Cation Channels | 1 | 2013 | 73 | 0.100 |
Why?
| | Dopaminergic Neurons | 1 | 2013 | 68 | 0.100 |
Why?
| | Oxygen | 3 | 2023 | 978 | 0.090 |
Why?
| | Microscopy, Fluorescence | 1 | 2014 | 408 | 0.090 |
Why?
| | Natriuretic Peptide, C-Type | 1 | 2012 | 5 | 0.090 |
Why?
| | GTP-Binding Protein gamma Subunits | 1 | 2012 | 10 | 0.090 |
Why?
| | GTP-Binding Protein beta Subunits | 1 | 2012 | 17 | 0.090 |
Why?
| | Mesenteric Arteries | 1 | 2012 | 17 | 0.090 |
Why?
| | Protein Isoforms | 1 | 2014 | 397 | 0.090 |
Why?
| | TRPV Cation Channels | 1 | 2012 | 43 | 0.090 |
Why?
| | Maze Learning | 2 | 2009 | 105 | 0.090 |
Why?
| | Disease Models, Animal | 4 | 2025 | 4560 | 0.090 |
Why?
| | Hyperalgesia | 1 | 2012 | 127 | 0.090 |
Why?
| | Peptides | 1 | 2017 | 998 | 0.080 |
Why?
| | Purinergic P2X Receptor Agonists | 1 | 2011 | 1 | 0.080 |
Why?
| | Purinergic P2X Receptor Antagonists | 1 | 2011 | 7 | 0.080 |
Why?
| | Protein Kinase C | 1 | 2012 | 251 | 0.080 |
Why?
| | Receptors, Purinergic P2X7 | 1 | 2011 | 12 | 0.080 |
Why?
| | Parasympathetic Fibers, Postganglionic | 1 | 2010 | 1 | 0.080 |
Why?
| | Lactic Acid | 2 | 2023 | 295 | 0.080 |
Why?
| | Zebrafish Proteins | 1 | 2013 | 314 | 0.080 |
Why?
| | N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2009 | 11 | 0.080 |
Why?
| | Phenylephrine | 2 | 2020 | 74 | 0.080 |
Why?
| | Rats, Sprague-Dawley | 3 | 2011 | 2524 | 0.080 |
Why?
| | Receptors, GABA-A | 1 | 2011 | 137 | 0.080 |
Why?
| | Sheep | 2 | 2023 | 876 | 0.070 |
Why?
| | Excitatory Postsynaptic Potentials | 1 | 2010 | 119 | 0.070 |
Why?
| | Regional Blood Flow | 2 | 2024 | 514 | 0.070 |
Why?
| | Young Adult | 3 | 2024 | 14219 | 0.070 |
Why?
| | Zebrafish | 1 | 2013 | 532 | 0.070 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2011 | 228 | 0.070 |
Why?
| | Motor Activity | 1 | 2013 | 718 | 0.070 |
Why?
| | Mice, Transgenic | 3 | 2025 | 2188 | 0.070 |
Why?
| | Membrane Potentials | 2 | 2007 | 278 | 0.070 |
Why?
| | Receptors, AMPA | 1 | 2010 | 147 | 0.070 |
Why?
| | Allosteric Site | 1 | 2007 | 17 | 0.070 |
Why?
| | Central Nervous System Stimulants | 1 | 2009 | 185 | 0.070 |
Why?
| | Drug Synergism | 2 | 2005 | 354 | 0.070 |
Why?
| | Space Perception | 2 | 2009 | 82 | 0.070 |
Why?
| | Action Potentials | 1 | 2010 | 502 | 0.060 |
Why?
| | Heart | 1 | 2010 | 626 | 0.060 |
Why?
| | Heart Rate | 1 | 2010 | 855 | 0.060 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2009 | 2028 | 0.060 |
Why?
| | Nerve Tissue Proteins | 1 | 2010 | 591 | 0.060 |
Why?
| | Synapses | 1 | 2010 | 439 | 0.060 |
Why?
| | Vasoconstrictor Agents | 2 | 2020 | 150 | 0.060 |
Why?
| | Receptors, Purinergic P2X2 | 1 | 2005 | 15 | 0.060 |
Why?
| | Cells, Cultured | 4 | 2016 | 4148 | 0.060 |
Why?
| | Cell Differentiation | 1 | 2013 | 2046 | 0.060 |
Why?
| | Renin | 1 | 2025 | 33 | 0.060 |
Why?
| | Phosphorylation | 2 | 2020 | 1707 | 0.060 |
Why?
| | Extracellular Space | 1 | 2005 | 117 | 0.060 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2005 | 376 | 0.050 |
Why?
| | Risk Factors | 1 | 2019 | 10885 | 0.050 |
Why?
| | Umbilical Arteries | 1 | 2024 | 52 | 0.050 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2005 | 531 | 0.050 |
Why?
| | Male | 9 | 2025 | 72843 | 0.050 |
Why?
| | Brain | 2 | 2024 | 2947 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 23 | 0.050 |
Why?
| | Binding Sites | 2 | 2005 | 1310 | 0.050 |
Why?
| | Microinjections | 1 | 2003 | 92 | 0.050 |
Why?
| | Membrane Proteins | 1 | 2010 | 1164 | 0.050 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2003 | 64 | 0.050 |
Why?
| | Chelating Agents | 1 | 2003 | 76 | 0.050 |
Why?
| | Glutamine | 1 | 2023 | 109 | 0.050 |
Why?
| | Ultrasonography, Prenatal | 1 | 2024 | 295 | 0.050 |
Why?
| | Serine | 1 | 2023 | 143 | 0.050 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2024 | 231 | 0.050 |
Why?
| | Mutation | 4 | 2019 | 4075 | 0.050 |
Why?
| | Amino Acid Substitution | 1 | 2003 | 302 | 0.040 |
Why?
| | Cerebrovascular Circulation | 1 | 2024 | 289 | 0.040 |
Why?
| | Glycine | 1 | 2023 | 186 | 0.040 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2025 | 454 | 0.040 |
Why?
| | Homeostasis | 2 | 2020 | 642 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 51 | 0.040 |
Why?
| | Memory | 1 | 2003 | 295 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2013 | 977 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 286 | 0.040 |
Why?
| | Gestational Age | 1 | 2024 | 987 | 0.040 |
Why?
| | Aminoimidazole Carboxamide | 1 | 2020 | 12 | 0.040 |
Why?
| | Ribonucleotides | 1 | 2020 | 26 | 0.040 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2020 | 49 | 0.040 |
Why?
| | Adolescent | 1 | 2019 | 22530 | 0.040 |
Why?
| | Glycolysis | 1 | 2021 | 340 | 0.040 |
Why?
| | Cyclic GMP | 1 | 2019 | 90 | 0.040 |
Why?
| | Ultrasonography, Doppler | 1 | 2020 | 126 | 0.040 |
Why?
| | Acetylcholine | 1 | 2020 | 208 | 0.040 |
Why?
| | RNA | 1 | 2005 | 910 | 0.040 |
Why?
| | Thiazolidinediones | 1 | 2020 | 139 | 0.040 |
Why?
| | Glutathione | 1 | 2020 | 370 | 0.040 |
Why?
| | Muscle, Smooth | 1 | 2019 | 153 | 0.040 |
Why?
| | Alanine | 1 | 2019 | 169 | 0.030 |
Why?
| | Biological Transport | 1 | 2019 | 424 | 0.030 |
Why?
| | Vasodilator Agents | 1 | 2020 | 330 | 0.030 |
Why?
| | Estrogens | 1 | 2020 | 367 | 0.030 |
Why?
| | Glucose | 1 | 2023 | 1048 | 0.030 |
Why?
| | Middle Aged | 1 | 2019 | 36215 | 0.030 |
Why?
| | Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2016 | 12 | 0.030 |
Why?
| | Cell Line | 2 | 2013 | 2823 | 0.030 |
Why?
| | Immunohistochemistry | 1 | 2020 | 1716 | 0.030 |
Why?
| | Pregnancy Trimester, Third | 1 | 2016 | 119 | 0.030 |
Why?
| | NIH 3T3 Cells | 1 | 2014 | 146 | 0.030 |
Why?
| | 1-Methyl-4-phenylpyridinium | 1 | 2013 | 5 | 0.030 |
Why?
| | Deferoxamine | 1 | 2013 | 27 | 0.030 |
Why?
| | Electroretinography | 1 | 2013 | 50 | 0.030 |
Why?
| | Tyrosine 3-Monooxygenase | 1 | 2013 | 72 | 0.030 |
Why?
| | Cyclooxygenase 2 | 1 | 2014 | 166 | 0.020 |
Why?
| | Melanocytes | 1 | 2013 | 65 | 0.020 |
Why?
| | Amino Acid Sequence | 2 | 2010 | 2129 | 0.020 |
Why?
| | Tetraethylammonium | 1 | 2012 | 16 | 0.020 |
Why?
| | DNA Primers | 1 | 2013 | 505 | 0.020 |
Why?
| | Larva | 1 | 2013 | 240 | 0.020 |
Why?
| | Molecular Sequence Data | 2 | 2010 | 2883 | 0.020 |
Why?
| | Potassium Channel Blockers | 1 | 2012 | 47 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2024 | 6447 | 0.020 |
Why?
| | Naphthalenes | 1 | 2012 | 54 | 0.020 |
Why?
| | Toll-Like Receptor 4 | 1 | 2014 | 276 | 0.020 |
Why?
| | Ganglia, Spinal | 1 | 2012 | 88 | 0.020 |
Why?
| | Angiotensin II | 1 | 2012 | 101 | 0.020 |
Why?
| | Hippocampus | 2 | 2010 | 971 | 0.020 |
Why?
| | Vasoconstriction | 1 | 2012 | 216 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2013 | 1300 | 0.020 |
Why?
| | Receptor, Muscarinic M2 | 1 | 2010 | 10 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 858 | 0.020 |
Why?
| | RNA Interference | 1 | 2012 | 475 | 0.020 |
Why?
| | Mice, 129 Strain | 1 | 2010 | 84 | 0.020 |
Why?
| | Sinoatrial Node | 1 | 2010 | 27 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1764 | 0.020 |
Why?
| | Indoles | 1 | 2014 | 507 | 0.020 |
Why?
| | Bradycardia | 1 | 2010 | 61 | 0.020 |
Why?
| | Blotting, Western | 1 | 2012 | 1179 | 0.020 |
Why?
| | Swimming | 1 | 2009 | 54 | 0.020 |
Why?
| | Hot Temperature | 1 | 2012 | 396 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2010 | 387 | 0.020 |
Why?
| | Sequence Alignment | 1 | 2010 | 362 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2009 | 1048 | 0.020 |
Why?
| | Visual Perception | 1 | 2009 | 184 | 0.020 |
Why?
| | Allosteric Regulation | 1 | 2007 | 99 | 0.020 |
Why?
| | Serotonin | 1 | 2009 | 297 | 0.020 |
Why?
| | Brain Chemistry | 1 | 2007 | 119 | 0.020 |
Why?
| | Neuronal Plasticity | 1 | 2009 | 305 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2007 | 160 | 0.010 |
Why?
| | Gene Expression Profiling | 1 | 2012 | 1767 | 0.010 |
Why?
| | Extracellular Fluid | 1 | 2005 | 38 | 0.010 |
Why?
| | Toxicity Tests | 1 | 2005 | 53 | 0.010 |
Why?
| | Metals, Heavy | 1 | 2005 | 31 | 0.010 |
Why?
| | Protein Conformation | 1 | 2007 | 938 | 0.010 |
Why?
| | Injections, Intraventricular | 1 | 2003 | 59 | 0.010 |
Why?
| | Neurotoxins | 1 | 2003 | 28 | 0.010 |
Why?
| | Evoked Potentials | 1 | 2005 | 131 | 0.010 |
Why?
| | Cysteine | 1 | 2005 | 211 | 0.010 |
Why?
| | Astrocytes | 1 | 2003 | 228 | 0.010 |
Why?
| | Protein Binding | 1 | 2007 | 2238 | 0.010 |
Why?
| | Aging | 1 | 2009 | 1969 | 0.010 |
Why?
| | Time Factors | 1 | 2009 | 7123 | 0.010 |
Why?
|
|
Lorca's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|